Sweet success? SGLT2 inhibitors and diabetes.
作者信息
Layton Anita T
机构信息
Departments of Mathematics, Biomedical Engineering, and Medicine, Duke University , Durham, North Carolina.
出版信息
Am J Physiol Renal Physiol. 2018 Jun 1;314(6):F1034-F1035. doi: 10.1152/ajprenal.00557.2017. Epub 2017 Dec 27.
Abstract
摘要
相似文献
1
Sweet success? SGLT2 inhibitors and diabetes.甜蜜的成功？钠-葡萄糖协同转运蛋白2抑制剂与糖尿病
Am J Physiol Renal Physiol. 2018 Jun 1;314(6):F1034-F1035. doi: 10.1152/ajprenal.00557.2017. Epub 2017 Dec 27.
2
Are SGLT2 Inhibitors Ready for Prime Time for CKD?钠-葡萄糖协同转运蛋白2抑制剂对慢性肾脏病而言已准备好进入黄金时期了吗？
Clin J Am Soc Nephrol. 2018 Feb 7;13(2):318-320. doi: 10.2215/CJN.07680717. Epub 2017 Sep 11.
3
Sodium Glucose Cotransporter 2 Inhibition Heralds a Call-to-Action for Diabetic Kidney Disease.钠-葡萄糖协同转运蛋白2抑制剂预示着糖尿病肾病防治行动的号角。
Clin J Am Soc Nephrol. 2020 Feb 7;15(2):285-288. doi: 10.2215/CJN.07730719. Epub 2019 Nov 18.
4
SGLT2 inhibitors and renal function.钠-葡萄糖协同转运蛋白2抑制剂与肾功能。
Med Lett Drugs Ther. 2016 Jul 18;58(1499):91-2.
5
Antihyperglycemic agents as novel natriuretic therapies in diabetic kidney disease.抗高血糖药物在糖尿病肾病中的新型利钠治疗作用。
Am J Physiol Renal Physiol. 2018 Nov 1;315(5):F1406-F1415. doi: 10.1152/ajprenal.00384.2017. Epub 2018 Aug 1.
6
More CREDENCE for SGLT2 Inhibition.钠-葡萄糖协同转运蛋白2（SGLT2）抑制剂的更多可信度证据。
Circulation. 2019 Oct 29;140(18):1448-1450. doi: 10.1161/CIRCULATIONAHA.119.041181. Epub 2019 Jun 11.
7
Deciphering the kidney hemodynamic effects of SGLT2 inhibition: translating insights from rats to humans in type 2 diabetes.解析 SGLT2 抑制对肾脏血流动力学的影响：将 2 型糖尿病大鼠研究结果转化至人体。
Kidney Int. 2024 Sep;106(3):354-356. doi: 10.1016/j.kint.2024.06.018.
8
Acute kidney injury from SGLT2 inhibitors: potential mechanisms.钠-葡萄糖协同转运蛋白2抑制剂所致急性肾损伤：潜在机制
Nat Rev Nephrol. 2016 Nov 16;12(12):711-712. doi: 10.1038/nrneph.2016.159.
9
Renoprotective Effects of SGLT2 Inhibitors: Beyond Glucose Reabsorption Inhibition.钠-葡萄糖协同转运蛋白2（SGLT2）抑制剂的肾脏保护作用：超越葡萄糖重吸收抑制
Curr Vasc Pharmacol. 2017;15(2):96-102. doi: 10.2174/1570161114666161007163426.
10
SGLT2 inhibition and kidney protection.SGLT2 抑制剂与肾脏保护。
Clin Sci (Lond). 2018 Jun 28;132(12):1329-1339. doi: 10.1042/CS20171298. Print 2018 Jun 29.
引用本文的文献
1
A Computational Model of Kidney Function in a Patient with Diabetes.糖尿病患者肾功能的计算模型。
Int J Mol Sci. 2021 May 29;22(11):5819. doi: 10.3390/ijms22115819.
2
Recent advances in renal epithelial transport.肾上皮转运的最新进展。
Am J Physiol Renal Physiol. 2019 Feb 1;316(2):F274-F276. doi: 10.1152/ajprenal.00510.2018. Epub 2018 Dec 5.
本文引用的文献
1
Harnessing basic and clinic tools to evaluate SGLT2 inhibitor nephrotoxicity.利用基础和临床工具评估钠-葡萄糖协同转运蛋白2抑制剂的肾毒性。
Am J Physiol Renal Physiol. 2017 Oct 1;313(4):F951-F954. doi: 10.1152/ajprenal.00250.2017. Epub 2017 Jun 21.
2
Saving the sweetness: renal glucose handling in health and disease.保留甜蜜：健康与疾病状态下的肾脏葡萄糖处理
Am J Physiol Renal Physiol. 2017 Jul 1;313(1):F55-F61. doi: 10.1152/ajprenal.00046.2017. Epub 2017 Mar 29.
3
A new microscope for the kidney: mathematics.一种用于肾脏的新型显微镜：数学
Am J Physiol Renal Physiol. 2017 Apr 1;312(4):F671-F672. doi: 10.1152/ajprenal.00648.2016. Epub 2017 Jan 18.
4
Increased Hematocrit During Sodium-Glucose Cotransporter 2 Inhibitor Therapy Indicates Recovery of Tubulointerstitial Function in Diabetic Kidneys.钠-葡萄糖协同转运蛋白2抑制剂治疗期间血细胞比容升高表明糖尿病肾病肾小管间质功能恢复
J Clin Med Res. 2016 Dec;8(12):844-847. doi: 10.14740/jocmr2760w. Epub 2016 Oct 26.
5
Renoprotective Effects of SGLT2 Inhibitors: Beyond Glucose Reabsorption Inhibition.钠-葡萄糖协同转运蛋白2（SGLT2）抑制剂的肾脏保护作用：超越葡萄糖重吸收抑制
Curr Vasc Pharmacol. 2017;15(2):96-102. doi: 10.2174/1570161114666161007163426.
6
Solute transport and oxygen consumption along the nephrons: effects of Na+ transport inhibitors.沿肾单位的溶质转运和氧消耗：Na+转运抑制剂的作用。
Am J Physiol Renal Physiol. 2016 Dec 1;311(6):F1217-F1229. doi: 10.1152/ajprenal.00294.2016. Epub 2016 Oct 5.
7
A computational model for simulating solute transport and oxygen consumption along the nephrons.一种用于模拟溶质沿肾单位转运及氧气消耗的计算模型。
Am J Physiol Renal Physiol. 2016 Dec 1;311(6):F1378-F1390. doi: 10.1152/ajprenal.00293.2016. Epub 2016 Oct 5.
8
Predicted consequences of diabetes and SGLT inhibition on transport and oxygen consumption along a rat nephron.糖尿病和钠-葡萄糖协同转运蛋白抑制对大鼠肾单位物质转运及氧消耗的预测后果。
Am J Physiol Renal Physiol. 2016 Jun 1;310(11):F1269-83. doi: 10.1152/ajprenal.00543.2015. Epub 2016 Jan 13.
9
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.恩格列净：在 2 型糖尿病中的心血管结局和死亡率。
N Engl J Med. 2015 Nov 26;373(22):2117-28. doi: 10.1056/NEJMoa1504720. Epub 2015 Sep 17.
10
Renal sodium-glucose cotransporter inhibition in the management of type 2 diabetes mellitus.肾钠-葡萄糖协同转运蛋白抑制在2型糖尿病管理中的应用
Am J Physiol Renal Physiol. 2015 Dec 1;309(11):F889-900. doi: 10.1152/ajprenal.00267.2015. Epub 2015 Sep 9.
Zotero 插件